Novel combinations comprising a phosphodiesterase-5 inhibitor and their use

Details for Australian Patent Application No. 2008254424 (hide)

Owner Vivus, Inc.

Inventors Held, Jerry M.

Agent FB Rice

Pub. Number AU-A-2008254424

PCT Pub. Number WO2008/144061

Priority 60/930,673 18.05.07 US; 60/962,094 27.07.07 US

Filing date 19 May 2008

Wipo publication date 27 November 2008

International Classifications

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/144061 Priority application(s): WO2008/144061

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254425-CSF-1R inhibitors, compositions, and methods of use

2008254423-Methods and compositions for producing solvents